CD34 and neoplasm: Transduced XLP1 patient BM CD34+ cells were also differentiated into NK cells and tested for functional recovery of NK cell cytotoxicity in a tumor killing assay with NK-sensitive target cells that express SLAM family receptors (Raji) and those that do not (K562).41